Test description
JAK2 exon 12 variants are observed in a significant number of V617F negative cases of polycythaemia vera (PV), and are included as a WHO major criterion for the diagnosis of PV.
Test information
Test name
JAK2 exon 12
Clinical indication
To aid in the differential diagnosis of patients with suspected polycythaemia vera where the JAK2 V617F variant is negative. This test is now only offered as part of the Myeloproliferative Neoplasm (MPN) panel of 31 genes.
Gene(s)
JAK2
Method
NGS (Next Generation Sequencing)
Turn around time
3 – 4 weeks
Medicare eligibility
73398 or 73399 – criteria apply
Price
If not MBS eligible please contact 1800 822 999 for details
Test request form
Standard pathology request form
Sample type
Blood 6mL EDTA tube or Bone Marrow 4mL EDTA tube
Collection type
Blood or bone marrow
Special instructions
None